Home / AMERICAN NEWS / Zohydro too dangerous for FDA’s OK?

Zohydro too dangerous for FDA’s OK?

Is Zohydro too dangerous?

FED UP!, an organization of over 40 consumer, health care and addiction-rehabilitation groups, thinks Zohydro is indeed too dangerous and they are urging the FDA (U.S. Food and Drug Administration) to reverse its approval of the new painkiller.  Zohyrdo is one of the drugs known as an opioid analgesic and was “green-lighted” by the FDA this past fall despite noteworthy reticence from the Fed’s own advisory committee which records show voted 11 to 2 against permitting the sale of Zohydro.

One concerned coalition, Public Citizen, claims that one dose of the highly addictive, hydrocodone-based drug Zohydro could kill a child.  The formal petition submitted to the Food and Drug Administration states that Zohydro is just too dangerous and goes on to say that there is simply no need for yet one more “high-dose opioid” or painkilling prescription narcotic.


Zohydro approved . . . but for how long?

In a media-shared letter to Dr. Margaret Hamburg, FDA Commissioner, FED UP! wrote: “In the midst of a severe drug epidemic fueled by overprescribing of opioids, the very last thing the country needs is a new, dangerous, high-dose opioid.  Too many people have already become addicted to similar opioid medications, and too many lives have been lost.”

In an earlier interview with CNN Dr. Brad Galer, executive vice president and chief medical officer at Zogenix, the pharmaceutical company behind Zohydro, stated: “We do not expect the introduction of Zohydro ER (extended release) to increase the overall use of opioids.  In fact, prescription data from the last five years shows that total use of ER opioids is constant and independent of new entrants to the market.”

Galer is confident that Zogenix will only target sales of Zohydro to a specific portion of the health care community and will focus on doctors who have exceptional experience prescribing prescription narcotics.  This will result in Zohydro only being given to “an appropriate group of patients” who suffer from chronic pain.

Both Zogenix and the Food and Drug Administration agree that the many benefits of Zohydro far outweigh any potential risks.  Furthermore Zogenix stated that Zohydro will be marketed with numerous warnings concerning abuse, potential addiction and possible misuse.  Regardless of these assurances, however, some doctors remain concerned.

Dr. Charles Reznikoff of the Hennepin County Medical Center in Minneapolis, Minnesota told the press: “The technology is out there to make this a safer pill. They just chose not to use it.  I would never prescribe it or recommend that it be prescribed. I would also recommend that the insurance companies not make it available to patients.”

Despite this cornucopia of cautious concern over the addictiveness of all opioid analgesics, patients with chronic pain will have access to Zohydro as early as next month.

(Image courtesy of PainAndDepression)

About Will Phoenix

W. Scott Phoenix, B.A., B.S. was born in Hawaii, raised in Pennsylvania and resides in California. He has been a published writer since 1978. His work has appeared (under various names) in numerous places in print and online including Examiner.com. He is a single parent of three children and has also worked as an actor, singer and teacher. He has been employed by such publications as the Daily Collegian and the Los Angeles Times.
  • FranktheMc

    Everyone who expresses concerns about this dangerous drug can never be able to get up the funds to bribe these people.

    • Will Phoenix

      Hi Frank!
      Thanks for your comment. It did seem strange to me that their own committee had reservations but they (the FDA) still OKed it. Thanks for reading my stuff! Fee free to share too!

  • InternetReader

    I live with chronic pain and was part of the drug study for Zohydro, and I can tell you first hand that it is a wonderful medication! My body responds well to hydrocodone, while other pain meds like morphine and OxyContin only provide marginal relief. I hurt every minute of every hour of every day, and while combinations of meds reduce the pain from a 9 to a 6-7, the only legal hydrocodone meds have acetaminophen which is damaging my liver.

    On Zohydro I was able to live a mostly normal life; today, I cannot do any physical exercise and I have to use a disabled sticker on my car because walking too far is unbearable. Thank God that Zohydro was approved and I eagerly await getting my prescription so that I can actually live my life instead of enduring never-ending torture.

    If you want to help the addicted, then end prohibition and treat them like patients instead of throwing them in prison. Alcohol kills many every year, but no one advocates prohibiting it again because it does not work, it removes others’ freedom of choice and leads to crime and a black market.

    • Will Phoenix

      Thank you for sharing your personal experience. It offers another perspective to the controversy. As always, thanks for reading my stuff too.

  • Will Phoenix

    Thank you too InternetReader for sharing your personal experience. I am sure others may add to their personal perspective on this issue after reading your post. Thanks for your comment and for reading my stuff.

642-874 74-678 70-243 hp2-z33 070-642 c2090-610 642-997 98-365 adm-201 aws-sysops 070-488 tk0-201 og0-093 300-135 ex0-005 70-347 300-101 icgb 3002 4a0-m01 c_tadm51_731 c_tscm62_66 640-875 mb6-703 pmi-sp icbb 1z0-808 300-320 1z0-052 70-466 itilfnd iia-cia-part3 c4090-971 400-101 cwna-106 1z0-803 9l0-012 70-448 mb2-704 640-722 070-347 412-79 2v0-620 hp2-z34 jn0-360 hp2-z31 070-411 1z0-061 400-051 pr000041 hp0-s42 070-412 hp2-b115 1z0-434 642-999 70-465 cissp 1y0-301 c2180-401 hp2-z12 mb6-704 ns0-157 070-486 300-115 mb5-705 640-864 642-889 70-488 352-001 070-483 cbap 2v0-621d 640-554 pmp 350-018 700-701 hp5-b04d 1z0-060 300-208 101 640-916 n10-006 70-341 9l0-422 700-501 1z0-053 70-480 jn0-660 70-410 070-461 a00-211 iia-cia-part1 70-487 c4040-252 300-206 hp0-s41 hp0-d31 220-802 70-687 98-367 210-260 tb0-123 1y0-201 70-462 ccd-410 200-120 dev-401 1v0-601 010-111 og0-091 070-487 1z0-062 hp0-a116 100-101 sk0-003 70-980 cca-500 2v0-621 70-417 cism 220-801 cisa 646-365 640-692 lx0-103 070-246 70-483 70-486 ex300 102-400 210-060 640-911 642-737 400-201 70-331 1z0-051 hp2-h35 500-260 hp0-y51 mb2-708 e10-001 pmi-rmp 101-400 070-480 70-533 300-070 98-349 cas-002 hp0-j73 c4040-251 pegacsa71v1 n10-005 700-039 sy0-401 70-463 642-980 jn0-102 e20-690 070-410 350-080 mb2-707 700-260 70-467 070-465 e05-001 70-413 312-49v8 98-364 prince2-foundation 1z0-804 1z0-047 vmce_v8 70-414 mb2-701 1z0-067 200-310 70-346 ex200 300-209 mb6-702 810-401 70-685 ns0-101 70-534 700-280 642-998 642-437 70-412 c_tfin52_66 70-532 1z0-133 p2080-099 itil c4040-250 810-403 70-662 1y0-400 ax0-100 300-075 70-461 70-411